Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18+
SponsorColumbia University

About this trial

This study will examine whether addition of dexmedetomidine or clonidine (two alpha-2 adrenergic agonists) will improve the comfort of patients during spinal anesthesia for cesarean delivery. When added to standard spinal anesthesia consisting of bupivacaine (a local anesthetic) and fentanyl and morphine (two opioids), these medications may decrease some of the pulling/tugging/pressure sensations that patients sometimes feel during cesarean delivery, may prolong the anesthetic time, and may decrease postoperative pain.

Eligibility criteria

Qualifiers

Pregnant women undergoing cesarean delivery with spinal anesthesia

Disqualifiers

Significant cardiovascular, psychiatric or respiratory disease

using opioids or with chronic pain syndrome

Multiple gestation

BMI >40 kg/m2

Trial design

Treatments tested in this trial

  • Clonidine
  • Dexmedetomidine

Treatment groups

150 Participants
are divided into 3 treatment groups

Sponsors and collaborators